AAUM (Average Assets Under Management) of ₹74.35 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| IT - Software | 12.4% | 14.2% | ▲ +1.8% |
| Capital Markets | 14.7% | 14.0% | ▼ -0.7% |
| Electrical Equipment | 12.9% | 11.4% | ▼ -1.6% |
| Food Products | 7.8% | 8.1% | ▲ +0.3% |
| Diversified FMCG | 7.8% | 7.6% | ▼ -0.3% |
| Automobiles | 4.3% | 4.7% | ▲ +0.4% |
| Aerospace & Defense | 4.5% | 4.7% | ▲ +0.1% |
| Non - Ferrous Metals | 4.5% | 4.5% | ● -0.1% |
| Industrial Products | 4.6% | 4.3% | ▼ -0.3% |
| Pharmaceuticals & Biotechnology | 3.8% | 4.0% | ▲ +0.3% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Capital Markets | 14.0% | 15.0% | ▲ +0.9% |
| IT - Software | 14.2% | 14.2% | ● +0.0% |
| Electrical Equipment | 11.4% | 11.4% | ● +0.1% |
| Food Products | 8.1% | 7.9% | ▼ -0.2% |
| Diversified FMCG | 7.6% | 7.0% | ▼ -0.5% |
| Non - Ferrous Metals | 4.5% | 4.9% | ▲ +0.4% |
| Automobiles | 4.7% | 4.8% | ▲ +0.1% |
| Aerospace & Defense | 4.7% | 4.8% | ▲ +0.1% |
| Pharmaceuticals & Biotechnology | 4.0% | 4.1% | ● +0.0% |
| Industrial Products | 4.3% | 4.0% | ▼ -0.3% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Multi Commodity Exchange of India Limited ₹3.09 Cr |
Capital Markets | 3.78% | 4.77% | +0.99% |
| 2 | Hindustan Zinc Limited ₹1.26 Cr |
Non - Ferrous Metals | 1.76% | 1.95% | +0.19% |
| 3 | National Aluminium Company Limited ₹1.23 Cr |
Non - Ferrous Metals | 1.74% | 1.90% | +0.16% |
| 4 | Dixon Technologies (India) Limited ₹2.19 Cr |
Consumer Durables | 3.23% | 3.38% | +0.15% |
| 5 | Oracle Financial Services Software Limited ₹1.08 Cr |
IT - Software | 1.52% | 1.67% | +0.15% |
| 6 | Hindustan Aeronautics Limited ₹2.85 Cr |
Aerospace & Defense | 4.25% | 4.39% | +0.14% |
| 7 | Hero MotoCorp Limited ₹2.83 Cr |
Automobiles | 4.23% | 4.37% | +0.14% |
| 8 | GlaxoSmithKline Pharmaceuticals Limited ₹60.21 L |
Pharmaceuticals & Biotechnology | 0.81% | 0.93% | +0.12% |
| 9 | K.P.R. Mill Limited ₹69.66 L |
Textiles & Apparels | 0.96% | 1.07% | +0.11% |
| 10 | Hitachi Energy India Limited ₹1.51 Cr |
Electrical Equipment | 2.26% | 2.33% | +0.07% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | ITC Limited ₹2.26 Cr |
Diversified FMCG | 3.82% | 3.49% | -0.33% |
| 2 | Cummins India Limited ₹2.28 Cr |
Industrial Products | 3.80% | 3.52% | -0.28% |
| 3 | Colgate Palmolive (India) Limited ₹1.33 Cr |
Personal Products | 2.30% | 2.06% | -0.24% |
| 4 | Page Industries Limited ₹1.12 Cr |
Textiles & Apparels | 1.95% | 1.73% | -0.22% |
| 5 | Hindustan Unilever Limited ₹2.30 Cr |
Diversified FMCG | 3.74% | 3.55% | -0.19% |
| 6 | Marico Limited ₹2.08 Cr |
Agricultural Food & other Products | 3.36% | 3.21% | -0.15% |
| 7 | HCL Technologies Limited ₹2.89 Cr |
IT - Software | 4.59% | 4.47% | -0.12% |
| 8 | Britannia Industries Limited ₹2.54 Cr |
Food Products | 4.04% | 3.92% | -0.12% |
| 9 | Coal India Limited ₹2.23 Cr |
Consumable Fuels | 3.54% | 3.44% | -0.10% |
| 10 | Nestle India Limited ₹2.57 Cr |
Food Products | 4.05% | 3.96% | -0.09% |
50 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹3.09 Cr |
Capital Markets |
4.77%
|
|
| 2 |
₹2.89 Cr |
IT - Software |
4.47%
|
|
| 3 |
₹2.85 Cr |
Aerospace & Defense |
4.39%
|
|
| 4 |
₹2.83 Cr |
Automobiles |
4.37%
|
|
| 5 |
₹2.75 Cr |
IT - Software |
4.24%
|
|
| 6 |
₹2.57 Cr |
Food Products |
3.96%
|
|
| 7 |
₹2.54 Cr |
Food Products |
3.92%
|
|
| 8 |
₹2.46 Cr |
IT - Software |
3.80%
|
|
| 9 |
₹2.30 Cr |
Diversified FMCG |
3.55%
|
|
| 10 |
₹2.28 Cr |
Industrial Products |
3.52%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.